Traditional cardiac risk factors in individuals with chronic kidney disease

被引:75
作者
Uhlig, K [1 ]
Levey, AS [1 ]
Sarnak, MJ [1 ]
机构
[1] Tufts Univ New England Med Ctr, Div Nephrol, Boston, MA 02111 USA
关键词
D O I
10.1046/j.1525-139X.2003.16028.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Individuals with chronic kidney disease (CKD) are at increased risk for the development and progression of cardiovascular disease (CVD). The increased risk is due to a higher prevalence of both traditional risk factors as well as nontraditional risk factors. In this review we focus on individuals at all stages of CKD and discuss modifiable traditional risk factors, namely hypertension, dyslipidemia, diabetes mellitus and poor glycemic control, smoking, and physical inactivity. The prevalence of each risk factor and its relationship with CVD is described. Treatment recommendations are provided using evidence available from populations with CKD or evidence extrapolated from the general population when there are insufficient data on individuals with CKD.
引用
收藏
页码:118 / 127
页数:10
相关论文
共 122 条
[61]   Achievement and safety of a low blood pressure goal in chronic renal disease - The Modification of Diet in Renal Disease Study Group [J].
Lazarus, JM ;
Bourgoignie, JJ ;
Buckalew, VM ;
Greene, T ;
Levey, AS ;
Milas, NC ;
Paranandi, L ;
Peterson, JC ;
Porush, JG ;
Rauch, S ;
Soucie, JM ;
Stollar, C .
HYPERTENSION, 1997, 29 (02) :641-650
[62]   Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? [J].
Levey, AS ;
Beto, JA ;
Coronado, BE ;
Eknoyan, G ;
Foley, RN ;
Kasiske, BL ;
Klag, MJ ;
Mailloux, LU ;
Manske, CL ;
Meyer, KB ;
Parfrey, PS ;
Pfeffer, MA ;
Wenger, NK ;
Wilson, PWF ;
Wright, JT .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :853-906
[63]   Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention [J].
Levin, A ;
Singer, J ;
Thompson, CR ;
Ross, H ;
Lewis, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (03) :347-354
[64]   Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes [J].
Lewis, EJ ;
Hunsicker, LG ;
Clarke, WR ;
Berl, T ;
Pohl, MA ;
Lewis, JB ;
Ritz, E ;
Atkins, RC ;
Rohde, R ;
Raz, I .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :851-860
[65]   THE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON DIABETIC NEPHROPATHY [J].
LEWIS, EJ ;
HUNSICKER, LG ;
BAIN, RP ;
ROHDE, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (20) :1456-1462
[66]  
Ligtenberg G, 2001, J AM SOC NEPHROL, V12, P368, DOI 10.1681/ASN.V122368
[67]   Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Lindholm, LH ;
Ibsen, H ;
Dahlöf, B ;
Devereux, RB ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Julius, S ;
Kjeldsen, SE ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H ;
Aurup, P ;
Edelman, J ;
Snapinn, S .
LANCET, 2002, 359 (9311) :1004-1010
[68]   CARDIAC-HYPERTROPHY, AORTIC COMPLIANCE, PERIPHERAL RESISTANCE, AND WAVE REFLECTION IN END-STAGE RENAL-DISEASE - COMPARATIVE EFFECTS OF ACE-INHIBITION AND CALCIUM-CHANNEL [J].
LONDON, GM ;
PANNIER, B ;
GUERIN, AP ;
MARCHAIS, SJ ;
SAFAR, ME ;
CUCHE, JL .
CIRCULATION, 1994, 90 (06) :2786-2796
[69]   Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE study [J].
Longenecker, JC ;
Coresh, J ;
Powe, NR ;
Levey, AS ;
Fink, NE ;
Martin, A ;
Klag, MJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (07) :1918-1927
[70]   DEATH RISK IN HEMODIALYSIS-PATIENTS - THE PREDICTIVE VALUE OF COMMONLY MEASURED VARIABLES AND AN EVALUATION OF DEATH RATE DIFFERENCES BETWEEN FACILITIES [J].
LOWRIE, EG ;
LEW, NL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 15 (05) :458-482